LMB763 (nidufexor)

selective FXR partial agonist

orally efficacious in NASH models

from two 3M compound HTS and LBD

J. Med. Chem., Jan. 15, 2020

Novartis (GNF), San Diego, CA

LMB763 (nidufexor) (Novartis (GNF) oral in vivo selective FXR partial agonist)

 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.